BIOARRAY BRIEFS | GenomeWeb

BIOARRAY BRIEFS

Premium

Nanogen Launches CF test, Gets Rights to HH Mutations

Nanogen said last week it had delivered its analyte specific reagents for the detection of the 25 gene mutations most commonly associated with cystic fibrosis to its first customer site for evaluation.

The test is designed for the company’s NanoChip molecular biology workstation, which includes the NanoChip microarray with electronic hybridization test sites.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.